• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Dezima Pharma - Articles and news items

TA-8995

Results from Phase 2b study of CETP inhibitor TA-8995 published

Industry news / 3 June 2015 / Victoria White

Dezima Pharma has announced the publication of the phase 2b TULIP study results with its CETP inhibitor, TA-8995, in patients with mild dyslipidaemia…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +